StemRIM
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
StemRIM made a loss over the last year. StemRIM owes ¥0.04 for every ¥1 it owns.
Compared with Healthcare companies in Japan · latest annual results Jul 2026.
P/E ratio
LossStemRIM made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.46The share price is 1.46 times StemRIM's book value per share, lower than 54% of Healthcare companies in Japan.
Market cap
¥9.0 BThe total market value of all of StemRIM's shares at today's price (share price × number of shares), smaller than 62% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥6.1 BWhat StemRIM would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Apr 2026).
Book value per share
¥97.73Net worth divided by the number of shares. The share price of ¥143.00 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-28.4%StemRIM lost 28.4% of its shareholders' money over the last year, lower than 83% of Healthcare companies in Japan.
Owes vs Owns
0.04×StemRIM owes ¥0.04 for every ¥1 it owns (low).
Dividend yield
NoneStemRIM does not currently pay a dividend.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For StemRIM: ¥9.0 B ÷ ¥6.1 B (30 Apr 2026) = 1.5.
What is StemRIM's return on equity?
StemRIM lost 28.4% of its shareholders' money over the last year, lower than 83% of Healthcare companies in Japan.
How much does StemRIM owe compared with what it owns?
StemRIM owes ¥0.04 for every ¥1 it owns (low).
Does StemRIM pay a dividend?
No. StemRIM does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.